Bank of New York Mellon’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-864
| Closed | -$5.14K | – | 4456 |
|
|
2022
Q4 | $5.14K | Sell |
864
-1
| -0.1% | -$6 | ﹤0.01% | 4448 |
|
|
2022
Q3 | $5K | Hold |
865
| – | – | ﹤0.01% | 4538 |
|
|
2022
Q2 | $7K | Hold |
865
| – | – | ﹤0.01% | 4568 |
|
|
2022
Q1 | $7K | Hold |
865
| – | – | ﹤0.01% | 4650 |
|
|
2021
Q4 | $8K | Hold |
865
| – | – | ﹤0.01% | 4613 |
|
|
2021
Q3 | $15K | Hold |
865
| – | – | ﹤0.01% | 4512 |
|
|
2021
Q2 | $18K | Hold |
865
| – | – | ﹤0.01% | 4384 |
|
|
2021
Q1 | $19K | Sell |
865
-124
| -13% | -$9.29K | ﹤0.01% | 4311 |
|
|
2020
Q4 | $62K | Hold |
989
| – | – | ﹤0.01% | 4132 |
|
|
2020
Q3 | $36K | Hold |
989
| – | – | ﹤0.01% | 4053 |
|
|
2020
Q2 | $30K | Hold |
989
| – | – | ﹤0.01% | 4031 |
|
|
2020
Q1 | $22K | Hold |
989
| – | – | ﹤0.01% | 4051 |
|
|
2019
Q4 | $31K | Sell |
989
-2,545
| -72% | -$94.7K | ﹤0.01% | 4142 |
|
|
2019
Q3 | $173K | Buy |
3,534
+919
| +35% | +$40.4K | ﹤0.01% | 3929 |
|
|
2019
Q2 | $119K | Sell |
2,615
-753
| -22% | -$35.6K | ﹤0.01% | 4003 |
|
|
2019
Q1 | $145K | Sell |
3,368
-30
| -0.9% | -$1.45K | ﹤0.01% | 3949 |
|
|
2018
Q4 | $160K | Sell |
3,398
-50
| -1% | -$5.75K | ﹤0.01% | 3893 |
|
|
2018
Q3 | $521K | Buy |
3,448
+31
| +0.9% | +$4.43K | ﹤0.01% | 3632 |
|
|
2018
Q2 | $613K | Sell |
3,417
-93
| -3% | -$21.7K | ﹤0.01% | 3527 |
|
|
2018
Q1 | $878K | Buy |
3,510
+227
| +7% | +$62.3K | ﹤0.01% | 3290 |
|
|
2017
Q4 | $941K | Buy |
3,283
+757
| +30% | +$216K | ﹤0.01% | 3286 |
|
|
2017
Q3 | $766K | Sell |
2,526
-4
| -0.2% | -$1.05K | ﹤0.01% | 3368 |
|
|
2017
Q2 | $591K | Buy |
2,530
+17
| +0.7% | +$4.45K | ﹤0.01% | 3527 |
|
|
2017
Q1 | $844K | Sell |
2,513
-96
| -4% | -$23.2K | ﹤0.01% | 3329 |
|
|
2016
Q4 | $532K | Buy |
2,609
+289
| +12% | +$68.9K | ﹤0.01% | 3565 |
|
|
2016
Q3 | $806K | Buy |
2,320
+40
| +2% | +$10.6K | ﹤0.01% | 3285 |
|
|
2016
Q2 | $474K | Buy |
2,280
+4
| +0.2% | +$882 | ﹤0.01% | 3566 |
|
|
2016
Q1 | $612K | Sell |
2,276
-261
| -10% | -$69.8K | ﹤0.01% | 3336 |
|
|
2015
Q4 | $1.06M | Buy |
2,537
+140
| +6% | +$62.6K | ﹤0.01% | 3132 |
|
|
2015
Q3 | $1.09M | Sell |
2,397
-597
| -20% | -$264K | ﹤0.01% | 3130 |
|
|
2015
Q2 | $1.51M | Buy |
2,994
+342
| +13% | +$157K | ﹤0.01% | 3095 |
|
|
2015
Q1 | $1.34M | Buy |
2,652
+691
| +35% | +$421K | ﹤0.01% | 3123 |
|
|
2014
Q4 | $1.18M | Sell |
1,961
-19
| -1% | -$7.62K | ﹤0.01% | 3208 |
|
|
2014
Q3 | $616K | Sell |
1,980
-2
| -0.1% | -$720 | ﹤0.01% | 3548 |
|
|
2014
Q2 | $781K | Buy |
1,982
+1,048
| +112% | +$432K | ﹤0.01% | 3437 |
|
|
2014
Q1 | $518K | Buy |
934
+192
| +26% | +$131K | ﹤0.01% | 3576 |
|
|
2013
Q4 | $467K | Buy |
+742
| New | +$248K | ﹤0.01% | 3602 |
|
|
2013
Q3 | – | Sell |
-120
| Closed | -$11K | – | 4217 |
|
|
2013
Q2 | $11K | Buy |
+120
| New | +$10.8K | ﹤0.01% | 4134 |
|
Other funds holding ACGN
HCM
TRCT
Bank of New York Mellon's ACGN Position: Q1 2023 in Review
Bank of New York Mellon sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 864 shares — an estimated $5.14K sold.
Bank of New York Mellon first reported a position in ACGN in Q2 2013 and held it in 38 quarters. The position peaked at $1.51M in Q2 2015. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.
- Bank of New York Mellon reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 864 Aceragen Inc shares in Q1 2023, an estimated $5.14K.
- Bank of New York Mellon first reported a position in Aceragen Inc in Q2 2013 and held it in 38 quarters.
- Bank of New York Mellon's Aceragen Inc position peaked at $1.51M in Q2 2015.
- 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.